Transketolase protein TKTL1 overexpression: A potential biomarker and therapeutic target in breast cancer

Oncology Reports

Volumn 17, Issue 4, 2007, Pages 841-845

  Földi, Martha ^a   Stickeler, Elmar ^a   Bau, Lidija ^a   Kretz, Oliver ^a   Watermann, Dirk ^a   Gitsch, Gerald ^a   Kayser, Gian ^a   Zur Hausen, Axel ^a   Coy, Johannes F ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b R Biopharm AG Rhome Ltd Scotland   (Germany)

Author keywords

Breast cancer; Transketolase like 1; Tumor metabolism; Warburg effect

Indexed keywords

TKTL1 PROTEIN, HUMAN; TRANSKETOLASE; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; BREAST TUMOR; DRUG ANTAGONISM; DRUG DESIGN; ENZYMOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; UPREGULATION;

BREAST NEOPLASMS; DRUG DESIGN; HUMANS; IMMUNOHISTOCHEMISTRY; TRANSKETOLASE; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 34249942508     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.4.841     Document Type: Article

References (29)

1. Warburg O, Posener K, Negelein E: Über den Stoffwechsel der Carcinomzelle. Biochem Z 152: 309-344, 1924.
2. Garber K: Energy boost: the Warburg effect returns in a new theory of cancer. J Natl Cancer Inst 96: 1805-1806, 2004.
3. Gatenby RA and Gillies RJ: Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4: 891-899, 2004. (Pubitemid 39472955)
4. Coy JF, Dressler D, Wilde J and Schubert P: Mutations in the transketolase-like gene TKTL1: clinical implications for neurodegenerative diseases, diabetes and cancer. Clin Lab 51: 257-273, 2005. (Pubitemid 40895125)
5. Boros LG, Puigjaner J, Cascante M, et al: Oxythiamine and dehydroepiandrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferation. Cancer Res 57: 4242-4248, 1997. (Pubitemid 27413432)
6. Rais B, Comin B, Puigjaner J, et al: Oxythiamine and dehydroepiandrosterone induce a G1 phase cycle arrest in Ehrlich's tumor cells through inhibition of the pentose cycle. FEBS Lett 456: 113-118, 1999. (Pubitemid 29339052)
7. Comin-Anduix B, Boren J, Martinez S, et al: The effect of thiamine supplementation on tumour proliferation. A metabolic control analysis study. Eur J Biochem 268: 4177-4182, 2001. (Pubitemid 32862878)
8. Schenk G, Duggleby RG and Nixon PF: Properties and functions of the thiamin diphosphate dependent enzyme transketolase. Int J Biochem Cell Biol 30: 1297-1318, 1998. (Pubitemid 29002974)
9. Coy JF, Dubel S, Kioschis P, et al: Molecular cloning of tissue-specific transcripts of a transketolase-related gene: implications for the evolution of new vertebrate genes. Genomics 32: 309-316, 1996.
10. Langbein S, Zerilli M, Zur Hausen A, et al: Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted. Br J Cancer 94: 578-585, 2006. (Pubitemid 43289763)
11. Isidoro A, Casado E, Redondo A, et al: Breast carcinomas fulfill the Warburg hypothesis and provide metabolic markers of cancer prognosis. Carcinogenesis 26: 2095-2104, 2005. (Pubitemid 41672197)
12. Robey IF, Lien AD, Welsh SJ, Baggett BK and Gillies RJ: Hypoxia-inducible factor-1alpha and the glycolytic phenotype in tumors. Neoplasia 7: 324-330, 2005. (Pubitemid 40664221)
13. Mottolese M, Nadasi EA, Botti C, et al: Phenotypic changes of p53, HER2, and FAS system in multiple normal tissues surrounding breast cancer. J Cell Physiol 204: 106-112, 2005. (Pubitemid 40776812)
14. Alo PL, Visca P, Botti C, et al: Immunohistochemical expression of human erythrocyte glucose transporter and fatty acid synthase in infiltrating breast carcinomas and adjacent typical/atypical hyperplastic or normal breast tissue. Am J Clin Pathol 116: 129-134, 2001.
15. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A and McGuire WL: Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177-182, 1987. (Pubitemid 17231334)
16. Revillion F, Bonneterre J and Peyrat JP: ERBB2 oncogene in human breast cancer and its clinical significance. Eur J Cancer 34: 791-808, 1998. (Pubitemid 28248487)
17. Xu RH, Pelicano H, Zhou Y, et al: Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res 65: 613-621, 2005.
18. Elstrom RL, Bauer DE, Buzzai M, et al: Akt stimulates aerobic glycolysis in cancer cells. Cancer Res 64: 3892-3899, 2004. (Pubitemid 38697301)
19. Buzzai M, Bauer DE, Jones RG, et al: The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation. Oncogene 24: 4165-4173, 2005. (Pubitemid 40961771)
20. Nebeling LC and Lerner E: Implementing a ketogenic diet based on medium-chain triglyceride oil in pediatric patients with cancer. J Am Diet Assoc 95: 693-697, 1995.
21. Seyfried TN and Mukherjee P: Targeting energy metabolism in brain cancer: review and hypothesis. Nutr Metab 2: 30, 2005.
22. Cobleigh MA, Vogel CL, Tripathy D, et al: Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J Clin Oncol 17: 2639-2648, 1999. (Pubitemid 29415219)
23. Vogel CL, Cobleigh MA, Tripathy D, et al: Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J Clin Oncol 20: 719-726, 2002. (Pubitemid 34111379)
24. Baselga J, Tripathy D, Mendelsohn J, et al: Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. J Clin Oncol 14: 737-744, 1996.
25. Slamon DJ, Leyland-Jones B, Shak S, et al: Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 344: 783-792, 2001. (Pubitemid 32222155)
26. Comin-Anduix B, Boros LG, Marin S, et al: Fermented wheat germ extract inhibits glycolysis/pentose cycle enzymes and induces apoptosis through poly(ADP-ribose) polymerase activation in Jurkat T-cell leukemia tumor cells. J Biol Chem 277: 46408-46414, 2002. (Pubitemid 35417635)
27. Du MX, Sim J, Fang L, et al: Identification of novel small-molecule inhibitors for human transketolase by high-throughput screening with fluorescent intensity (FLINT) assay. J Biomol Screen 9: 427-433, 2004.
28. Boros LG, Lapis K, Szende B, et al: Wheat germ extract decreases glucose uptake and RNA ribose formation but increases fatty acid synthesis in MIA pancreatic adenocarcinoma cells. Pancreas 23: 141-147, 2001. (Pubitemid 32692123)
29. Jakab F, Shoenfeld Y, Balogh A, et al: A medical nutriment has supportive value in the treatment of colorectal cancer. Br J Cancer 89: 465-469, 2003. (Pubitemid 37026426)